ENTITY

Tonix Pharmaceuticals Holding (TNXP US)

4
Analysis
Health CareUnited States
Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company that develops therapies for disorders of the central nervous system ("CNS"). The Company develops therapies for disorders that include fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"),
more
Refresh
19 May 2017 18:00Issuer-paid

Time to execute

With the commencement of enrolment for the pivotal Phase III HONOR study of TNX-102 SL in military-related post-traumatic stress disorder (PTSD),...

Share
20 Apr 2017 17:49Issuer-paid

HONOR study up and running

Tonix Pharmaceuticals has commenced enrolment for the Phase III HONOR study of TNX-102 SL in military-related post-traumatic stress disorder...

Share
23 Jan 2017 22:19Issuer-paid

Breakthrough Therapy Designation in PTSD

Tonix has announced that it has been granted Breakthrough Therapy Designation (BTD) by the FDA as its Phase II AtEase data for TNX-102 SL in...

Share
01 Dec 2016 20:30Issuer-paid

PTSD awareness day and earnings update

Tonix recently held a post-traumatic stress disorder (PTSD) awareness day to highlight the current standards of care, the unmet medical need of the...

Share
No more insights
x